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Introduction
Swine influenza (swine flu) is considered to be a 
respiratory disease of pigs caused by influenza virus (SIV, 
zoonotic disease). This illness was originally transmitted 
from pigs to humans but now easily spreads from one 
person to another. The symptoms of swine flu are totally 
similar to those of regular influenza and include fever, 
headaches, chills, diarrhoea, coughing and sneezing 
(1,2). The pandemic swine flu caused by the SIV subtype 
H1N1, including other subtypes H1N2, H1N3, H3N1, 
H3N2 and H2N3 can also cause illness. The virus was 
termed H1N1 because it mainly exhibited two types of 
antigens hemagglutinin (H) 1 and neuraminidase (N) 1 
(3,4). Several vaccines are now available to prevent and/
or against the disease. Generally, a healthy person may 
become infected by inhaling droplets expelled into the air 
through coughing or sneezing of an infected person or by 
transmission of virus-contaminated surfaces. However, 
the disease is not transmitted directly by eating cooked 
pork (1-5). The number of cases related to this virus 
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Implication for health policy/practice/research/medical education:
Aqueous leaves extracts of Azadirachta indica, Butea frondosa and Ficus religiosa are capable of enhancing both antibody and cell 
mediated immune responses against Swine flu vaccine antigen in mice and might be used in manufacturing active adjuvant for 
vaccine antigen.
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Introduction: In general, primary or secondary metabolites derived from medicinal plant 
products might be responsible for stimulating or suppressing the immune system against specific 
protein antigens. The objective of this study was to evaluate the adjuvant potential of aqueous 
leaves extract of Azadirachta indica, Butea frondosa and Ficus religiosa against Swine flu vaccine 
antigen.
Methods: In this study, our group evaluated the antibody (IgG) titre of Swine flu vaccine antigen (2 
µg/mL) using variable doses (0.625–5 mg) of aqueous leaves extract of A. indica, B. frondosa and F. 
religiosa. In addition, Swiss mice were immunized subcutaneously (100 µL) on day 0 with Swine flu 
vaccine antigen (1:1000 dilution). Splenocytes were collected on day 7 and cultured with variable 
doses of aqueous leaves extract of A. indica, B. frondosa and F. religiosa pertaining to determine 
the total cellular content and splenocyte proliferation (Swine flu vaccine; Ovalbumin, OVA and 
Con A) assay. In addition, estimation of Th1 (IFN-gamma and TNF alpha) cytokines in cell culture 
supernatant containing swine flu vaccine antigen along with aqueous leaves extract were measured.
Results: Aqueous leaves extract of A. indica, B. frondosa and F. religiosa showed anti-Swine flu titre 
at higher doses. In ex vivo animal model studies these three medicinal plants in the form of aqueous 
leaves extract enhanced total cellular content at higher doses but increased in splenocyte proliferation 
(Swine flu vaccine, OVA and Con A) assay at lower doses. Similarly, there was enhancement in Th1 
cytokines (IFN-gamma, TNF alpha) with respect to swine flu vaccine antigen containing aqueous 
extract at lower doses as compared to control group.
Conclusion: Aqueous leaves extract of A. indica, B. frondosa and F. religiosa showed adjuvant activity 
against Swine flu vaccine antigen and might be used in manufacturing active adjuvant for vaccine 
antigen.
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shoots up during summer and monsoon season. In this 
regard, researchers have focused on various medicinal 
plants to control the burden of this disease.
Immunological exploration of these medicinal plants is 
totally based on phytochemical screening of primary and 
secondary metabolites (6). These metabolites of medicinal 
plants were examined for their immunopharmacological 
activities and approaches which lead to drug discovery 
and commonly referred as screening of natural products. 
Most of the medicinal plant products in the form of 
secondary metabolites i.e. flavonoids, terpenoids, saponin, 
etc. have shown anti-inflammatory, anti-microbial and 
immunosuppressive activities against specific as well as 
non-specific antigens (7-10). In addition, these metabolites 
from medicinal plant products are routinely used as raw 
material for extraction of active ingredients (11) that were 
used actually in the synthesis and manufacturing of active 
candidates e.g. adjuvants and vaccine antigens. 
Azadirachta indica (Family Meliaceae; Common name, 
Neem) and Butea frondosa (Family Fabaceae; Common 
name, Palas) medicinal plants have shown many properties 
including anti-inflammatory, anti-hyperglycemic, 
antiulcer, antimalarial, antibacterial and antioxidant 
properties related to human health (7-13). Ficus religiosa 
(Peepal tree; family Moraceae) is found in tropical and 
subtropical regions of India. As per Ayurveda, isolation 
and purification of bioactive candidates from these herbal 
plants have shown various immunopharmacological 
activities so that they can be used to treat several types 
of diseases such as asthma, diabetes and inflammatory 
disorders (14). This study aimed to focus on the 
immunoadjuvant activities of medicinal plants namely 
A. indica, B. frondosa and F. religiosa against Swine flu 
vaccine antigen.
Materials and Methods
Plant material
Fresh leaves of A. indica, B. frondosa and F. religiosa were 
collected from Nakshatra Udyan of Vidya Pratishthan 
(Baramati, Maharashtra, India). The collected leaves 
were dried at room temperature and then macerated 
with a mortar and pestle. Powdered samples (5 g) of each 
plant were macerated in 50 mL of phosphate buffered 
saline (PBS, pH 7.2) and centrifuged at 10000 rpm. 
The supernatant was collected for estimation of various 
immunological assays. All these samples were stored at 
4°C.
Qualitative analysis of secondary metabolites
The presence of secondary metabolites, i.e. terpenoids 
(using acetic anhydride test); flavonoids (using lead 
acetate test); saponins (using foam test) and phenolics 
(using ferric chloride test) was confirmed in aqueous 
leaves extracts of A. indica, B. frondosa and F. religiosa. 
Swine flu vaccine
Inactivated influenza vaccines (surface antigen IP; 0.25 
mL) were used in these studies. The influenza virus surface 
antigens (haemagglutinin and neuraminidase) were 
comprised of three different strains i.e. A/California/7/2009 
(HIN1) pdm09-like strain (A/California/7/2009, X-181)- 
7.5 µg HA; A/Hong)-Kong/4801/2014 (H3N2)-like strain 
(A/New Caledonia/71/2014, x-257A)- 7.5 µg HA; B/
Brisbane/60/2008-like strain (B/Brisbane/60/2008, wild 
type)- 7.5 µg HA with a total volume of 250 µL. All strains 
were propagated in fertilized hens’ eggs from healthy 
chicken flocks containing haemagglutinin as well as traces 
of eggs, i.e. OVA, Chicken proteins, etc.
ELISA assay
Indirect ELISA was performed using Swine flu 
vaccine (1:1000 dilution) as coating antigen. Variable 
concentrations of aqueous leaves extract of seven different 
medicinal plants, i.e. Ficus religiosa, Syzygium cumini, 
Butea frondosa, Emblica officinalis, Terminalia arjuna, 
Prosopis spicigera and Azadirachta indica were added 
and their Swine flu IgG antibody titers were determined. 
Horse anti-serum was used as secondary antibody and 
the absorbance in the form of optical density (OD) was 
measured at 450 nm (15).
Estimation of total cellular content
In ex vivo studies, Swiss mice (n = 5) were immunized 
subcutaneously (100 µL) on day 0 with Swine flu vaccine 
antigen (1:100 dilution; formulated containing three 
different strains in a final volume of 250 µL). On day 7, 
spleen cells were collected from peritoneal cavity of the 
mouse. Red blood cells from each spleen were then lysed 
with red cell lysis buffer. Finally, the cells were flushed out 
with PBS containing 10% FBS in order to prepare a single-
cell suspension from the spleen of mouse. Splenocytes 
(100 µL cells containing 105 cells/well) were cultured in 
96-well, flat-bottom tissue culture plates for 48. This 
incubation period was done along with variable doses 
of aqueous leaves extract of A. indica, B. frondosa and F. 
religiosa (0.312-5 mg; 50 µL) in the presence of swine flu 
vaccine antigen (2 µg/mL; 50 µL), OVA (50 µg/well; 50 
µL) and Con A (5 µg/mL; 50 µL). Three different sets of 
experiments were performed simultaneously. The samples 
were centrifuged at 15 000 rpm. The supernatant was 
collected in order to determine the total cellular or protein 
contents using NanoDrop 1000 A280 module. The Beer 
Lambert equation (A=E*b*c) was applied for all protein 
calculations to correlate absorbance with concentration.
Splenocyte proliferation assay and analysis of Th1 
cytokines 
Similarly, in another set of experiment performed MTT 
assay splenocytes were cultured and incubated at 37°C 
in 5% carbon dioxide incubator along with variable 
doses of aqueous leaves extracts in presence of swine 
flu vaccine antigen, OVA and Con A and determined 
their proliferation rate. After incubation, the medium 
was collected, centrifuged for the estimation of Th1 
(IFN-gamma and TNF alpha) cytokines and then added 
fresh PBS containing 10 % FBS. MTT solution (2.5 mg/
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ml; 10 µL) was added and then the plate was incubated 
for another 4 h at carbon dioxide incubator. Formazan 
crystals were appeared and settled at the bottom and then 
dissolved in dimethyl sulphoxide (DMSO) solution after 
centrifuging and discarding the supernatant. The OD was 
measured at 570 nm (16).
Briefly, 100 µL of diluted capture antibody (IFN-gamma 
and TNF alpha; 2 µg/mL) was added to each well in 
96-well plates and allowed to adhere overnight at 4°C. 
The plates were washed properly and blocked in 1X 
PBS supplemented with 10% FBS for 1 hour at room 
temperature. After washing, serial dilutions of the standard 
and samples were prepared and incubated for 2 hours. The 
plates were then washed and the working detector solution 
(including detector antibody and avidin–horse radish 
peroxidase reagent) was added into each well. Plates were 
sealed and incubated at room temperature for 1 hour. 
After washing, 100 µL of tri-methyl benzidine (TMB) 
substrate was added into each well. The stop solution (2 
N H2SO4) was finally added after incubation in the dark 
for 30 minutes at room temperature. The absorbance was 
read at 450 nm. The result was analyzed using softmax 
program and values were determined against the standard 
provided by the manufacturer (16).
Haemolytic activity
The haemolytic activity of human whole blood was 
determined using aqueous leaves extract of A. indica, B. 
frondosa and F. religiosa. Distilled water was used as a 
control. In this study, human whole blood suspension was 
collected from Mangal Pathology Laboratory, Baramati. 
Whole blood samples were prepared by diluting in PBS 
along with variable concentrations of aqueous leaves 
extracts of A. indica, B. frondosa and F. religiosa. The 
samples were incubated in a carbon dioxide incubator for 
2 hours. After incubation, the blood samples containing 
aqueous leaves extract were centrifuged. The supernatants 
were collected and using spectrophotometer, the free 
hemoglobin in the supernatants was estimated. The OD 
was measured at 405 nm (14).
Results
ELISA assay
Determination of antibody production against Swine flu 
vaccine antigen was done through ELISA. As shown in 
Figure 1, out of seven, only three aqueous leaves extracts of 
A. indica, B. frondosa and F. religiosa showed enhancement 
in antibody production against Swine flu vaccine antigen 
as compared to the control group.
Total cellular content
As shown in Table 1, aqueous leaves extracts of A. indica, 
B. frondosa and F. religiosa showed enhancement in total 
cellular content with respect to Swine flu vaccine and 
OVA, antigen at higher doses as compared to the control 
group.
Proliferation assay
The effects of aqueous leaves extracts of three different 
medicinal plants were evaluated to determine splenocyte 
proliferation assay against Swine flu vaccine antigen, OVA 
and Con A (Figure 2). The results show that aqueous 
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Figure 1. ELISA assay. Indirect ELISA was performed using Swine flu vaccine (1:1000 dilution) as coating antigen. Variable concentration 
of aqueous leaves extract of seven different medicinal plants were added and determined its Swine flu IgG antibody titre. Horse anti-serum 
was used as secondary antibody and absorbance in the form of optical density was measured at 450 nm.
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leaves extracts of A. indica, B. frondosa and F. religiosa 
raised splenocyte proliferation at lower doses as compared 
to the control group. Swine flu vaccine antigen, OVA and 
Con A were used as standards in this study and showed an 
enhancement in proliferation as compared to the control 
group.
Analysis of Th1 cytokines by ELISA
As shown in Figure 3, aqueous leaves extracts of A. indica, 
B. frondosa and F. religiosa raised Th1 (IFN-gamma and 
TNF alpha) production at lower doses as compared to the 
control group.
Haemolytic activity
The effects of aqueous leaves extracts of three different 
medicinal plants evaluated to determine their haemolytic 
activities in the human whole blood (Figure 4). The results 
showed that aqueous extracts of three medicinal plants 
had not any haemolytic effect at higher doses as compared 
to the control group. On the other hand, distilled water 
showed higher haemolytic activity.
Discussion
Phytochemicals are bioactive compounds that are present 
in medicinal plants and applied in traditional herbal 
medicines. Generally, these herbal medicines are used for 
curing various human diseases especially diabetes, cancer, 
HIV etc. The objective of our study was to determine 
qualitatively screening of phytochemicals within aqueous 
leaves extracts of three medicinal plants and estimating 
the antibody titer and proliferation rate (using specific and 
non-specific antigen) against Swine flu vaccine antigen. 
These medicinal plants were screened and evaluated in the 
form of aqueous leaves extracts for adjuvant activity against 
different vaccine antigens. These adjuvants are needed for 
vaccine antigen in order to enhance its immunogenicity 
against various infectious diseases. Searching for those 
active molecules derived from medicinal plants which are 
responsible for inducing or stimulating both humoral and 
cell-mediated immune responses is necessary. For the last 
several years, only one adjuvant has been approved for 
human use, i.e. alum which increases humoral response. 
However it poorly elicits cell-mediated immunity. In 
addition, emulsion-based adjuvant, i.e. MF59 provokes 
both humoral and cell mediated immune response. 
Recently, a trivalent vaccine, namely Fluad, formulated 
with MF59 (effective for 65 years or more; US approved) 
has been produced from three strains of influenza (2 
subtype A and 1 type B) for prevention of seasonal 
influenza (17). In view of this, adjuvants are required for 
vaccine antigen pertaining to increase its immunogenicity, 
avidity and also help in decreasing the dose of antigen to 
decrease the toxicity. In this regard, efforts have been made 
in order to reduce the burden of antigen using various 
medicinal plants and to use as adjuvant against vaccine 
antigens. The most important benefit of these adjuvant-
based plants is that they would remain stable for longer 
period of time. Generally, secondary metabolites from 
medicinal plants, used as adjuvant for vaccine antigen, are 
still under investigation, e.g. QS21 (saponin from Quillaja 
saponaria); RLJ-NE-299A (glycosides from Picrorhiza 
Kurroa) (11,18). In this study, we got similar results and 
these medicinal plants in the form of aqueous extract 
containing various phytochemicals showed enhancement 
in antibody production against Swine flu vaccine antigen. 
Further immunological ex vivo studies were also 
conducted in those splenocytes were cultured and 
exposed to swine flu vaccine, OVA and Con A in aqueous 
leaves extract and showed dose dependent changes in 
proliferation and total cellular content as compared to 
control group. In addition, specific (swine flu vaccine, 
OVA) and non-specific (Con A) antigens were recognized 
strongly by aqueous leaves extract containing primary as 
well as secondary metabolites and antibody-secreting cells 
from vaccines (11). Studying this interaction will allow us 
to further elucidate the effectiveness of antigen adjuvant 
combinations. In contrast, these medicinal plants showed 
no haemolytic effects as compared to distilled water. 
Table 1. Effect of variable doses of aqueous leaves extract of medicinal plants on total cellular content in mouse splenocytes
Treatment Doses (mg/mL)
0.156 0.312 0.625 1.25 2.5
Swine flu vaccine
Control 0.424 ± 0.02 - - - - -
A. indica - 0.544 ± 0.04 0.617 ± 0.02 0.982 ± 0.08 1.145 ±0.12 1.342 ± 0.22***
B. frondosa - 0.750 ±  0.06 0.868 ± 0.14 0.912 ± 0.22 1.022 ± 0.34 1.232 ± 0.42**
F. religiosa - 0.475 ± 0.02 0.412 ± 0.06 0.448 ± 0.04 0.568 ± 0.06 0.814 ± 0.12*
 OVA
Control 0.377 ±0.02 - - - - -
A. indica - 0.562 ± 0.08 0.725 ± 0.06 0.986 ± 0.14 1.023 ± 0.13 1.214 ± 0.18**
B. frondosa - 0.340 ± 0.02 0.425 ± 0.02 0.827 ± 0.08 0.924 ± 0.16 1.012 ± 0.22*
F. religiosa - 0.319 ± 0.02 0.464 ± 0.04 0.683 ± 0.04 0.712 ± 0.06 0.784 ± 0.14
Swiss mice were immunized with swine flu vaccine on day 0. Splenocytes were collected on day 7 and cultured with variable doses of aqueous leaves 
extract and then further exposed with Swine flu vaccine antigen and OVA. Total cellular content was measured after high speed centrifugation and 
collect supernatant for estimation of total cellular content. Values are expressed as Mean ± S.E. The difference between control and variable doses of 
aqueous extract is controlled by one-way ANOVA test (Bonferroni multiple comparison test). *P < 0.05; **P < 0.01 and ***P < 0.001.
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Furthermore, aqueous leaves extract were able to induce 
anti-Swine flu, anti-OVA and anti-Con A T-helper cell 
response as shown by the strong antigen-specific/non-
specific cell proliferation. Cytokine determination showed 
that aqueous extract adjuvanted Swine flu vaccine induced 
more IFN- gamma and TNF production as compared to 
control group. In short, we can be concluded on the basis 
of antibody production, proliferation and cytokines (IFN-
gamma and TNF alpha) that aqueous extracts of the plants 
induce Th1 immune response. These observations suggest 
that the use of these aqueous extract as an adjuvant for 
swine flu vaccine antigen may provide better protection 
against these antigens by eliciting both humoral and 
cellular immune responses. 
Conclusion
The results of this study indicated that aqueous leaves 
extracts of these plants might be considered as better 
vaccine adjuvant candidates in order to enhance the 
immunogenicity or antibody production, proliferation 
and Th1 cytokines against Swine flu vaccine antigen. The 
need for exploring alternative plant based formulation 
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Figure 2. Splenocyte proliferation assay. Swiss mice were immunized subcutaneously on day 0 with swine flu vaccine antigen. On day 7, 
Splenocytes were collected and cultured with variable doses of aqueous leaves extract (0.312- 2.5 mg/mL; 50 µL) and then exposed to A) 
swine flu vaccine antigen (2 µg/mL; 50 µL), B) OVA (50 µg/well; 50 µL) and C) Con A (5 µg/mL; 50 µL)and determined its proliferation as-
say using MTT. Values are expressed as mean ± SE. The difference between control and variable doses of aqueous extract was controlled 
by one way ANOVA test (Bonferroni multiple comparison test). *P < 0.05; **P < 0.01 and ***P < 0.001.
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for Swine flu vaccine antigen may raise the next step in 
this evaluation to test aqueous extract as an adjuvant with 
other protein antigens. Further studies with these aqueous 
extracts adjuvanted with Swine flu vaccine antigen are 
needed to establish clinically relevant proof of principles. 
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Figure 3. Th1 (IFN-gamma and TNF alpha) cytokines. Swiss mice were immunized subcutaneously on day 0 with swine flu vaccine 
antigen. On day 7, splenocytes were collected and cultured with variable doses of aqueous leaves extract (0.312- 2.5 mg/mL; 50 µL) and 
then exposed to swine flu vaccine antigen (2 µg/mL; 50 µL). Incubate the plate for another 24h. The plate was centrifuged and the super-
natant was collected for the estimation of Th1 cytokines which determined by Elisa. Values are expressed as mean ± SE. The difference 
between control and variable doses of aqueous extract was determined by one way ANOVA test (Bonferroni multiple comparison test). 
*P < 0.05; **P < 0.01 and ***P < 0.001.
Figure 4. Haemolytic activity. Whole blood samples were diluted in PBS along with variable concentrations of aqueous leaves extracts 
(0.312- 2.5 mg/mL; 50 µL). The samples were incubated for 2 hours at carbon dioxide incubator. After incubation, the blood samples were 
centrifuged and the supernatants were collected and the free haemoglobin was estimated in the supernatants using spectrophotometer. 
The OD was measured at 405 nm.
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